1. Home
  2. LBRX vs AMAL Comparison

LBRX vs AMAL Comparison

Compare LBRX & AMAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LB Pharmaceuticals Inc

LBRX

LB Pharmaceuticals Inc

HOLD

Current Price

$47.00

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo Amalgamated Financial Corp. (DE)

AMAL

Amalgamated Financial Corp. (DE)

N/A

Current Price

$48.99

Market Cap

1.5B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
LBRX
AMAL
Founded
2015
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Commercial Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.5B
IPO Year
2025
2020

Fundamental Metrics

Financial Performance
Metric
LBRX
AMAL
Price
$47.00
$48.99
Analyst Decision
Strong Buy
Hold
Analyst Count
5
2
Target Price
$46.60
$36.00
AVG Volume (30 Days)
285.4K
130.8K
Earning Date
05-06-2026
04-23-2026
Dividend Yield
N/A
1.68%
EPS Growth
98.22
N/A
EPS
N/A
1.99
Revenue
N/A
N/A
Revenue This Year
N/A
$21.18
Revenue Next Year
N/A
$6.55
P/E Ratio
N/A
$24.85
Revenue Growth
N/A
N/A
52 Week Low
$13.40
$25.13
52 Week High
$50.16
$51.59

Technical Indicators

Market Signals
Indicator
LBRX
AMAL
Relative Strength Index (RSI) 56.39 55.41
Support Level $21.90 $36.50
Resistance Level $49.65 $51.25
Average True Range (ATR) 2.02 0.95
MACD -0.53 -0.20
Stochastic Oscillator 30.43 53.75

Price Performance

Historical Comparison
LBRX
AMAL

About LBRX LB Pharmaceuticals Inc

LB Pharmaceuticals Inc is a late-stage biopharmaceutical company developing novel therapies for the treatment of a wide range of neuropsychiatric disorders including schizophrenia, bipolar depression, adjunctive treatment of depressive disorder and other diseases. It is building a pipeline that leverages the broad therapeutic potential of its product candidate, LB-102, which it believes has the potential to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States. LB-102 is currently in late-stage clinical development for schizophrenia and bipolar depression. The company operates as a single reportable segment in the development of novel therapies for the treatment of neuropsychiatric diseases, including schizophrenia.

About AMAL Amalgamated Financial Corp. (DE)

Amalgamated Financial Corp is a bank holding company. It is a full-service commercial bank and a chartered trust company. It provides commercial banking and trust services nationally and offers various products and services to commercial and retail customers. It offers a complete suite of commercial and retail banking, investment management, and trust and custody services.

Share on Social Networks: